PLRX
NASDAQ
$1.07
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and markets new therapies for the treatment of fibrosis and related diseases in the United States. The company is headquartered in South San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $2.50 (+133.64%)
Market Cap
$69M
P/B Ratio
0.41
Beta (5Y)
1.20
Price Chart
Valuation
Market Cap$69M
P/S3071.82
P/B0.41
Profitability
EBITDA-$118M
EPS-$1.84
Growth & Risk
EPS 5Y CAGR-2.79%
FCF 5Y CAGR+14.34%
Beta (5Y)1.20
Sharpe Ratio-0.29